Losartan kidney damage
Pro Research Analysisby 
Searched over 200M research papers
Losartan and Kidney Damage: A Comprehensive Review
Introduction to Losartan and Kidney Health
Losartan, an angiotensin II receptor antagonist, is widely used to manage hypertension and protect kidney function. This article synthesizes research findings on the effects of losartan on kidney damage, particularly in conditions such as diabetic nephropathy, acute kidney injury (AKI), and chronic kidney disease (CKD).
Losartan in Diabetic Nephropathy
Renal Protection in Type 2 Diabetes
Diabetic nephropathy is a leading cause of end-stage renal disease. Research indicates that losartan significantly slows the progression of renal disease in patients with type 2 diabetes. In a study involving 1513 patients, losartan reduced the incidence of doubling serum creatinine levels and end-stage renal disease by 25% and 28%, respectively, compared to placebo . Additionally, losartan decreased proteinuria by 35%, highlighting its protective role against kidney damage in diabetic patients .
Losartan and Acute Kidney Injury (AKI)
Reducing AKI to CKD Transition
AKI is a significant risk factor for developing CKD. Studies using murine models have shown that losartan can mitigate the progression from AKI to CKD. Losartan administration post-AKI reduced mortality, blood pressure, albuminuria, azotemia, and kidney fibrosis, suggesting its efficacy in preventing long-term kidney damage following AKI .
Ischemia/Reperfusion Injury
Ischemia/reperfusion (I/R) injury is another cause of AKI. Research indicates that losartan, alone or combined with angiotensin 1-7, significantly reduces serum markers of kidney damage such as blood urea nitrogen (BUN) and creatinine levels post-I/R injury . This protective effect underscores losartan's potential in managing acute renal injuries.
Losartan in Chronic Kidney Disease (CKD)
Tubulointerstitial Damage and Proteinuria
In CKD with proteinuria, losartan has been shown to decrease urinary kidney injury molecule 1 (KIM-1) levels, a biomarker for early tubular damage. This reduction parallels the decrease in proteinuria, suggesting that losartan ameliorates proteinuria-induced tubular damage .
Oxidative Stress and Renal DNA Damage
Losartan also reduces oxidative damage to renal DNA in diabetic rats, preserving plasma antioxidant capacity. This reduction in oxidative stress markers, such as 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodGuo), indicates losartan's role in protecting against oxidative renal damage .
Losartan in Specific Renal Conditions
Cisplatin-Induced Nephrotoxicity
Cisplatin, a chemotherapy drug, is known for its nephrotoxic effects. Studies comparing losartan and vitamin E as prophylaxes against cisplatin-induced nephrotoxicity found that both agents demonstrated protective effects. However, the combination of losartan and vitamin E did not show additional benefits, possibly due to pharmacokinetic or pharmacodynamic interactions .
Obstructive Nephropathy
In models of obstructive nephropathy, losartan has been shown to ameliorate renal fibrosis by upregulating regulatory T cells (Tregs), which play a role in immune regulation and fibrosis reduction . This finding suggests that losartan may accelerate the repair process in obstructive kidney diseases.
Intermittent Hypoxia-Induced Kidney Damage
Chronic intermittent hypoxia, as seen in obstructive sleep apnea, can lead to peritubular capillary loss and kidney damage. Losartan has been found to protect against this damage by modulating the renal renin-angiotensin system and balancing angiogenesis factors, thereby preserving kidney function .
Conclusion
Losartan demonstrates significant protective effects against various forms of kidney damage, including diabetic nephropathy, AKI, CKD, and specific renal conditions like cisplatin-induced nephrotoxicity and obstructive nephropathy. Its ability to reduce oxidative stress, proteinuria, and fibrosis, while preserving renal function, underscores its therapeutic potential in managing kidney diseases.
Sources and full results
Most relevant research papers on this topic